Patents by Inventor Jeffrey Alan McKinney
Jeffrey Alan McKinney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230303571Abstract: The present invention relates to Ibogaine derivatives and related methods. It more specifically relates to deutero- and fluoro-derivatives of Ibogaine and related methods. In one aspect, the present invention provides a compound. The structure of the compound is shown as compound 1 in FIG. 1. In another aspect, the present invention provides a method of treating an addiction disorder. The method comprises administration of compound 1. In another aspect, the present invention provides a method of treating an anxiety-related disorder or impulse control disorder. The method comprises administration of compound 1.Type: ApplicationFiled: May 1, 2023Publication date: September 28, 2023Inventor: Jeffrey Alan McKinney
-
Patent number: 11680066Abstract: The present invention relates to Ibogaine derivatives and related methods. It more specifically relates to deutero- and fluoro-derivatives of Ibogaine and related methods. In one aspect, the present invention provides a compound. The structure of the compound is shown as compound 1 in FIG. 1. In another aspect, the present invention provides a method of treating an addiction disorder. The method comprises administration of compound 1. In another aspect, the present invention provides a method of treating an anxiety-related disorder or impulse control disorder. The method comprises administration of compound 1.Type: GrantFiled: May 13, 2021Date of Patent: June 20, 2023Inventor: Jeffrey Alan McKinney
-
Emulsions and extended release formulations including cannabis-derived compounds and related methods
Publication number: 20210378958Abstract: The present invention generally relates to emulsions and extended release formulations including cannabis-derived compounds and related methods. It more specifically relates to emulsion-based and extended release formulations. In one aspect, the present invention is directed to an emulsion. The emulsion includes a compound derived from cannabis and an active ingredient. In another aspect, the present invention is directed to an extended release formulation. The formulation includes a compound derived from cannabis and an active ingredient.Type: ApplicationFiled: May 14, 2021Publication date: December 9, 2021Inventor: Jeffrey Alan McKinney -
Publication number: 20210371423Abstract: The present invention relates to Ibogaine derivatives and related methods. It more specifically relates to deutero- and fluoro-derivatives of Ibogaine and related methods. In one aspect, the present invention provides a compound. The structure of the compound is shown as compound 1 in FIG. 1. In another aspect, the present invention provides a method of treating an addiction disorder. The method comprises administration of compound 1. In another aspect, the present invention provides a method of treating an anxiety-related disorder or impulse control disorder. The method comprises administration of compound 1.Type: ApplicationFiled: May 13, 2021Publication date: December 2, 2021Inventor: Jeffrey Alan McKinney
-
Publication number: 20200181051Abstract: The present invention is generally directed to deuterated agonists and their methods of use. It is more specifically directed to deuterated alpha-7 nicotinic receptor agonists and their methods of use. In one aspect, the present invention involves compounds of the structure 1-34 as shown in FIGS. 1-4. In another aspect, the present invention involves the treatment of a disorder with a compound of the structure 1-34 as shown in FIGS. 1-4.Type: ApplicationFiled: November 15, 2019Publication date: June 11, 2020Inventor: Jeffrey Alan McKinney
-
Publication number: 20180099208Abstract: The present invention generally relates to two-wheel, three-wheel or four-wheel electric boards, methods of making and using the boards, and power sources used to propel the boards. In one aspect the present invention provides a two-wheel, three-wheel or four-wheel electric board. The board includes: at least one truck and one battery case attached to a deck; at least two wheels attached to the at least one truck; an electric motor operably connected to at least one wheel and electrically connected to the battery case, wherein there is at least one battery in the battery pack, and wherein the at least one battery comprises a lithium-titanate-based anode.Type: ApplicationFiled: October 5, 2017Publication date: April 12, 2018Inventor: Jeffrey Alan Mckinney
-
Patent number: 9409997Abstract: The present invention is generally directed to functionalized graphene substrates, methods of making such substrates and methods of using such substrates. In one aspect, the present invention provides a graphene substrate. The substrate comprises edge and non-edge regions, and organic or inorganic molecules are bound to the edge regions of the substrate. The organic or inorganic molecules are present on the substrate edges at a population greater than about one molecule per 10,000 nm.Type: GrantFiled: May 23, 2014Date of Patent: August 9, 2016Assignee: Nanotech Biomachines, Inc.Inventors: Jeffrey Alan McKinney, William Emerson Martinez
-
Patent number: 9402910Abstract: The present invention is generally directed to internally functionalized graphene substrates, methods of making such substrates and methods of using such substrates. In one aspect, the present invention is a graphene substrate. The substrate comprises edge and non-edge regions. Organic or inorganic molecules are bound to the non-edge regions of the substrate, and the organic or inorganic molecules are present on the substrate edges at a population greater than about one molecule per 10,000 nm2.Type: GrantFiled: July 9, 2014Date of Patent: August 2, 2016Assignee: Nanotech Biomachines, Inc.Inventors: Jeffrey Alan McKinney, William Emerson Martinez
-
Publication number: 20150313941Abstract: The present invention is generally directed to compositions and methods for amelioration of diseases and related symptoms in domestic animals. In one aspect, the invention is directed to a method of ameliorating the symptoms of arthritis, brain aging, cataracts, diabetes, dermatitis, FLUTD, glaucoma, low energy levels or obesity in a domestic animal, wherein the method comprises administering a composition to the animal, wherein the composition comprises a Fruit-Based Additive, a Vegetable-Based Additive or a Fruit- and Vegetable-Based Additive.Type: ApplicationFiled: April 17, 2015Publication date: November 5, 2015Inventor: Jeffrey Alan McKinney
-
Publication number: 20150314005Abstract: The present invention is generally directed to compositions and methods for amelioration of diseases and related symptoms in humans. In one aspect, the invention is directed to a method of ameliorating the symptoms of arthritis, brain aging, cataracts, diabetes, dermatitis, chronic renal failure, glaucoma, low energy levels or obesity in a human, wherein the method comprises administering a composition to the animal, wherein the composition comprises a Fruit-Based Additive, a Vegetable-Based Additive or a Fruit- and Vegetable-Based Additive.Type: ApplicationFiled: March 24, 2015Publication date: November 5, 2015Inventor: Jeffrey Alan McKinney
-
Publication number: 20150017699Abstract: The present invention is generally directed to internally functionalized graphene substrates, methods of making such substrates and methods of using such substrates. In one aspect, the present invention is a graphene substrate. The substrate comprises edge and non-edge regions. Organic or inorganic molecules are bound to the non-edge regions of the substrate, and the organic or inorganic molecules are present on the substrate edges at a population greater than about one molecule per 10,000 nm2.Type: ApplicationFiled: July 9, 2014Publication date: January 15, 2015Applicant: NANOTECH BIOMACHINES, INC.Inventors: Jeffrey Alan McKinney, William Emerson Martinez
-
Publication number: 20150004667Abstract: The present invention is generally directed to functionalized graphene substrates, methods of making such substrates and methods of using such substrates. In one aspect, the present invention provides a graphene substrate. The substrate comprises edge and non-edge regions, and organic or inorganic molecules are bound to the edge regions of the substrate. The organic or inorganic molecules are present on the substrate edges at a population greater than about one molecule per 10,000 nm.Type: ApplicationFiled: May 23, 2014Publication date: January 1, 2015Applicant: NANOTECH BIOMACHINES, INC.Inventors: Jeffrey Alan McKinney, William Emerson Matinez
-
Publication number: 20140322358Abstract: The present invention is generally directed to compositions and methods for amelioration chronic renal failure and related symptoms in domestic animals. In one case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Fruit- and Vegetable-Based Additive. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Cesium and/or Rubidium salt. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Dehydrated Domestic Animal Food and a Phosphate Binder.Type: ApplicationFiled: April 24, 2014Publication date: October 30, 2014Inventor: Jeffrey Alan McKinney
-
Patent number: 6232313Abstract: The present invention relates to compounds, pharmaceutical compositions and methods of using compounds having the formula below in the treatment and prevention of certain diseases or conditions. Where the ring designated A is chosen from ortho substituted aryl or heteroaryl species, R1 and R2 are chosen independently from —(CH2)nL where L is selected from a variety of substituents including hydrogen, and aryl, heteroaryl or heterocyclic groups and R4 is chosen from a variety of substituents including halogen and alkyl groups. The compounds are useful in treating and preventing neurological disorders associated with excitatory amino acids.Type: GrantFiled: March 19, 1998Date of Patent: May 15, 2001Assignee: Zeneca LimitedInventors: Thomas Michael Bare, Timothy Wayne Davenport, James Roy Empfield, Jeffrey Alan McKinney, Richard Bruce Sparks
-
Patent number: 6214826Abstract: The invention relates to pyridazinoquinoline compounds of the formulas B and B′ wherein Ring A is selected from an ortho fused aromatic or heteroaromatic five- or six-membered ring and R1, R3 and R4 are substituents selected from halo, OH, OCF3, NO2, CN, NR′R″, SO2NR′R″, SOmR′alkyl, and a variety of alkyl, aryl, heterocyclic and heteroaryl groups, to pharmaceutical compositions containing them and to methods utilizing them for the treatment of neurological disorders.Type: GrantFiled: August 2, 1999Date of Patent: April 10, 2001Assignee: Zeneca LimitedInventors: Thomas Michael Bare, Marc Jerome Chapdelaine, Timothy Wayne Davenport, James Roy Empfield, Laura Enid Garcia-Davenport, Paul Francis Jackson, Jeffrey Alan McKinney, Charles David McLaren, Richard Bruce Sparks
-
Patent number: 6103721Abstract: The present invention concerns compounds according to the following formula, ##STR1## wherein: R.sup.1 is (CH.sub.2).sub.n,L where n is an integer in the range 0 to 6, and L is a carbon-linked five-membered heteroaryl ring having an oxygen or sulfur heteroatom, R.sup.4 is hydrogen, halo or NO.sub.2, and pharmaceutical compositions and methods of using thereof in the treatment and/or prevention of neurological diseases or conditions.Type: GrantFiled: December 6, 1999Date of Patent: August 15, 2000Assignee: Zeneca LimitedInventors: Thomas Michael Bare, Timothy Wayne Davenport, James Roy Empfield, Jeffrey Alan McKinney, Richard Bruce Sparks
-
Patent number: 5744471Abstract: The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula (I) in the treatment and/or prevention of certain diseases or conditions. In formula (I), A is chosen from ortho substituted aryl or heteroaryl species, X is chosen from --OH, --SH, NHR and R.sup.1 or R.sup.2 is chosen from --(CH.sub.2).sub.n L wherein L may be selected from a variety of substituents including aryl, heteroaryl and heterocyclic groups. The compounds are useful in treating and/or preventing neurological disorders associated with excitatory amino acids.Type: GrantFiled: April 17, 1996Date of Patent: April 28, 1998Assignee: Zeneca LimitedInventors: Thomas Michael Bare, Timothy Wayne Davenport, James Roy Empfield, Jeffrey Alan McKinney, Richard Bruce Sparks